Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
University of Southern California
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
PharmaEssentia
City of Hope Medical Center
RWTH Aachen University
Italfarmaco